NR5A1 and Hypergonadotropic hypogonadism: This argues strongly for the inclusion of NR5A1 in 1st-tier genetic testing panels for any child presenting with unexplained hypospadias, ambiguous genitalia, or gonadal dysgenesis, especially when accompanied by biochemical evidence of hypergonadotropic hypogonadism.